AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ACRUX LTD

0.010

0.000

Volume:500.00K

Turnover:5K

Market Cap:5.90M

PE:-1.73

High:0.010

Open:0.010

Low:0.010

Close:0.010

52wk High:0.021

52wk Low:0.009

Shares:589.68M

Float Shares:300.39M

Volume Ratio:1.38

T/O Rate:0.17%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.006

EPS(LYR):-0.017

ROE:-48.51%

ROA:-1.79%

PB:4.02

PE(LYR):-0.59

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies-1.25%

Capital Flow

Inflow:

Outflow:

News

Acrux Ltd-Acrux Appoints Chief Medical Officer

THOMSON REUTERS

Acrux Ltd-Update - Licensing Lenzetto for Australia for AUD5.4m

THOMSON REUTERS

Acrux Ltd - Licenses Lenzetto for Australian Market for AUD 5.4 Mln

THOMSON REUTERS

BRIEF-Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/ACR.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACR.AU\",,,,,undefined,":{"symbol":"ACR.AU","market":"AU","secType":"STK","nameCN":"ACRUX LTD","latestPrice":0.01,"timestamp":1787897520000,"preClose":0.01,"halted":0,"volume":500000,"delay":0,"changeRate":0,"nameEN":"ACRUX LTD","floatShares":300389644,"shares":589677802,"eps":-0.005785,"marketStatus":"Not Yet Opened","change":0,"latestTime":"08-28 16:12:00 AEST","open":0.01,"high":0.01,"low":0.01,"amount":5000,"amplitude":0,"askPrice":0.011,"askSize":1152632,"bidPrice":0.01,"bidSize":1225312,"shortable":3,"etf":0,"ttmEps":-0.005785,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1788134400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.01,"openAndCloseTimeList":[[1787875200000,1787896800000]],"volumeRatio":1.3848267309397413,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"ACR.AU","preClose":0.01,"auctionPrice":0.011,"auctionVolume":13573,"auction":3,"marketStatus":"盘后竞价","timestamp":1787810435201}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACR.AU\",,,,,undefined,":{"symbol":"ACR.AU","floatShares":300389644,"roa":"-1.79%","roe":"-48.51%","lyrEps":-0.016881,"volumeRatio":1.3848267309397413,"shares":589677802,"dividePrice":0,"high":0.01,"amplitude":0,"preClose":0.01,"low":0.01,"week52Low":0.009,"pbRate":"4.02","psRate":"0.89","week52High":0.021,"institutionHeld":0,"latestPrice":0.01,"committee":0.030564,"eps":-0.005785,"divideRate":0,"volume":500000,"delay":0,"ttmEps":-0.005785,"open":0.01,"prevYearClose":0.015,"prevWeekClose":0.01,"prevMonthClose":0.01,"prevQuarterClose":0.012,"fiveDayClose":0.01,"twentyDayClose":0.01,"sixtyDayClose":0.012},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACR.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-02-23","symbol":"ACR.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1708606800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACR.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661249246","title":"Acrux Ltd-Acrux Appoints Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2661249246","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661249246?lang=en_us&edition=fundamental","pubTime":"2026-08-24 07:44","pubTimestamp":1787528698,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260823:nTUE6TLHP8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACR.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639083648","title":"Acrux Ltd-Update - Licensing Lenzetto for Australia for AUD5.4m","url":"https://stock-news.laohu8.com/highlight/detail?id=2639083648","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639083648?lang=en_us&edition=fundamental","pubTime":"2026-05-29 10:19","pubTimestamp":1780021181,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nTUE8R8SS8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","ACR.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638463477","title":"Acrux Ltd - Licenses Lenzetto for Australian Market for AUD 5.4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2638463477","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638463477?lang=en_us&edition=fundamental","pubTime":"2026-05-28 07:05","pubTimestamp":1779923124,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nFWN42416B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ACR.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638571400","title":"BRIEF-Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2638571400","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638571400?lang=en_us&edition=fundamental","pubTime":"2026-05-27 14:35","pubTimestamp":1779863714,"startTime":"0","endTime":"0","summary":"BRIEF-Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia    May 27  - Richter Gedeon Vegyeszeti Gyar Nyrt GDRB.BU says in a statement on the Budapest Stock Exchange:AGREES WITH ACRUX ON EXTENSION OF ITS LICENSE AGREEMENT DATED 2013 RELATING TO TRANSDERMAL ESTRADIOL SPRAY LENZETTO TO AUSTRALIAN MARKETAMENDED AGREEMENT PROVIDES RICHTER EXCLUSIVE COMMERCIALIZATION RIGHTS FOR THE AUSTRALIAN MARKETRICHTER SAYS ACRUX WILL RECEIVE TOTAL PAYMENTS OF AUD 5.4 MILLION OVER THE COMING PERIODSource text: [ID:]Further company coverage: GDRB.BU  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nB3N41W00G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","ACR.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ACR.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":-0.012496}]}}